📢 For Latest Job Updates
📲 Join WhatsApp Channel
💼 Follow on LinkedIn
✔ Verified by Medical Jobs India
Clinical Trial Associate (CTA)
ICON plc
Bangalore
0–2 Years
Clinical Research
TMF & Documentation
Full-Time
🏢 About ICON plc
ICON plc is a leading global CRO supporting innovative drug development programs across multiple therapeutic areas. The company partners with pharmaceutical and biotech organizations to deliver clinical development solutions worldwide.
📌 Job Overview
- Role: Clinical Trial Associate (CTA)
- Location: Bangalore
- Experience: 0–2 Years
- Qualification: Life Sciences / Pharmacy / Healthcare
- Industry: Clinical Research & CRO
🔬 Key Responsibilities
- Assist in coordination & administration of clinical trials
- Ensure compliance with ICH-GCP & regulatory requirements
- Maintain Trial Master Files (TMF)
- Prepare study documents (ICF, CRF, essential files)
- Track trial milestones & performance metrics
- Coordinate with clinical operations & data teams
- Support audit & inspection documentation
🎓 Eligibility & Qualifications
- Bachelor’s degree in Life Sciences, Pharmacy, Biotechnology, Nursing, or related field
- Understanding of clinical trial processes & ICH-GCP
- Strong documentation & organizational skills
- Excellent communication skills
- Internship experience in clinical research preferred
- Freshers with strong interest in clinical research may apply
💰 Salary & Benefits
Estimated Salary: ₹3.8 – ₹6.5 LPA
- Health insurance & retirement benefits
- Annual leave & wellness support
- Global Employee Assistance Program
- Life insurance coverage
- Flexible benefits & childcare support
⭐ Why Join ICON?
- Work on global clinical trials
- Career growth in clinical operations
- Strong CRO industry exposure
- Supportive & inclusive work culture
📌 Note Before You Apply:
Candidates with TMF management knowledge and ICH-GCP understanding will have a strong advantage.
Candidates with TMF management knowledge and ICH-GCP understanding will have a strong advantage.
👇 Apply Online 👇
⏳ Apply link unlocks in:
15

0 Comments